Crypto Co

During the nine months ended September 30, 2025, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

On November 17, 2025, Ronald Levy voluntarily resigned from his position as Chief Operating Officer of the Company. Such resignation is not due to any disagreement with the Company, its management, or its board of directors, and does not constitute a resignation from his positions as Chief Executive Officer, Interim Chief Financial Officer, Chairman of the Board, or Secretary. Also on November 17, 2025, the Board of Directors of the Company appointed Jared Strasser to serve as the Company’s Chief Operating Officer, effective immediately. Prior to joining the Company, Mr. Strasser served as the President of Technology Conversion Co.. There are no arrangements or understandings between Mr. Strasser and any other person pursuant to which Mr. Strasser was appointed as Chief Operating Officer. There are no family relationships between Mr. Strasser and any director or executive officer of the Company, and there are no related-party transactions with Mr. Strasser reportable under Item 404(a) of Regulation S-K. The Company is currently negotiating an employment agreement for Mr. Strasser, which will be submitted to the Board of Directors for approval. The Company expects to enter into an employment agreement with Mr. Strasser upon the terms approved by the Board.

On May 23, 2025, the Company issued a total of 83,603,144 shares of common stock, in lieu of cash to seven different consultants proving services to the Company.

On June 24, 2025 and June 25, 2025, the Company entered into stock agreement with five recipients to issue a total of 386,459,998 shares as a bonus to employees and contractors for services. Ronald Levy the Company’s CEO received 197,605,773 of those Common Shares and Holly Ruxin, a director, received 67,106,721 of those Common Shares. The Common Shares received by Mr. Levy and Ms. Ruxin were on the same terms and conditions as the other Recipients.

During the quarter, the Company completed regulatory review of the restatement of the financial statements included in the Form 10-K for the year ended December 31, 2023, including the impact on prior periods. In connection with this review, the Company updated and enhanced its disclosures to reflect the restatement and provide additional clarity.